Login to Your Account

FDA: No Authority to Accept FY14 User Fees

FDA Shuts the Door on NDAs, sNDAs

By Mari Serebrov
Washington Editor

Thursday, October 3, 2013
Don’t bother to submit new drug and supplemental applications (NDAs) during the government shutdown, the FDA is telling drugmakers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription